Ads

 

Ads

 

Ads

 

World Top 100 Healthcare Companies List by Market Cap in January 2024

World Top 100 Healthcare Companies List by Market Cap in January 2024, World Biggest 100 Healthcare Companies by Market Cap, World Largest 100 Healthcare Companies in the World by market cap as pf Jan-05-2024.

Metatag Title
World Top Healthcare Companies in 2024
Metatag Abstract
World Top Healthcare Companies by Market Cap in 2024, World Top Healthcare Companies by Market Cap in 2024.
  1. Yuhan Corporation

    World Rank (Jan-05-2024)
    3,626
    Market Cap (Jan-05-2024)
    3.827 Billion USD
    World Rank (Jul-30-2023)
    3,765
    Market Cap (Jul-30-2023)
    3.686 Billion USD
    World Rank (Dec-25-2022)
    3,979
    Market Cap (Dec-25-2022)
    3.113 Billion USD
    World Rank (Jan-07-2022)
    11,585
    Market Cap (Jan-07-2022)
    0.68 Billion USD
    Annual Revenue in USD
    1,262 Million USD
    Annual Net Income in USD
    77 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile
    Pharmaceutical company with headquarters is in South Korea.
  2. Turning Point Therapeutics

    World Rank (Jan-05-2024)
    3,662
    World Rank (Jul-30-2023)
    3,662
    Market Cap (Jul-30-2023)
    3.810 Billion USD
    World Rank (Dec-25-2022)
    6,535
    Market Cap (Dec-25-2022)
    1.510 Billion USD
    World Rank (Jan-07-2022)
    6,033
    Market Cap (Jan-07-2022)
    2.13 Billion USD
    Annual Revenue in USD
    30 Million USD
    Annual Net Income in USD
    -236 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile

    Turning Point Therapeutics is a clinical-stage biopharmaceutical company designing and developing novel small molecule, targeted oncology therapies to address key limitations of existing therapies and improve the lives of patients. Headquarters is in USA.

    Turning Point develops kinase inhibitors, a class of targeted cancer drugs, that are designed to bind to cancer cells with greater precision and affinity than existing therapies.

  3. Krka D. D.

    World Rank (Jan-05-2024)
    3,668
    Market Cap (Jan-05-2024)
    3.773 Billion USD
    World Rank (Jul-30-2023)
    3,727
    Market Cap (Jul-30-2023)
    3.730 Billion USD
    World Rank (Dec-25-2022)
    3,973
    World Rank (Jan-07-2022)
    3,973
    Annual Revenue in USD
    1,796 Million USD
    Annual Net Income in USD
    341 Million USD
    Annual Results for Period Ending
    Dec-2020 ending year
    Headquarters Country
    Company Profile

    KRKA develop and market innovative generic medicines. Headquarters is in Slovenia.

  4. Guangzhou Kingmed Diagnostics Group

    World Rank (Jan-05-2024)
    3,674
    Market Cap (Jan-05-2024)
    3.768 Billion USD
    World Rank (Jul-30-2023)
    3,111
    Market Cap (Jul-30-2023)
    4.738 Billion USD
    World Rank (Dec-25-2022)
    2,899
    Market Cap (Dec-25-2022)
    4.668 Billion USD
    World Rank (Jan-07-2022)
    2,595
    Market Cap (Jan-07-2022)
    6.68 Billion USD
    Annual Revenue in USD
    1,738 Million USD
    Annual Net Income in USD
    323 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile
    Guangzhou Kingmed Diagnostics Group is the Leading Independent Clinical Testing Laboratory company in China. It provides more than 2,700 tests for clinical and scientific research purposes and more than 50 countries and regions worldwide. The company quarterly revenue is 2,303.8 million USD, quarterly net income is 1,118.2 million USD and 10,714 employees as on 2020. The headquarters is in China.
  5. Glaukos Corporation

    World Rank (Jan-05-2024)
    3,675
    Market Cap (Jan-05-2024)
    3.765 Billion USD
    World Rank (Jul-30-2023)
    3,766
    Market Cap (Jul-30-2023)
    3.681 Billion USD
    World Rank (Dec-25-2022)
    5,389
    Market Cap (Dec-25-2022)
    2.034 Billion USD
    World Rank (Jan-07-2022)
    5,846
    Market Cap (Jan-07-2022)
    2.23 Billion USD
    Annual Revenue in USD
    282 Million USD
    Annual Operating Income in USD
    -102 Million USD
    Annual Net Income in USD
    -99 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile
    Glaukos Corporation is an Ophthalmic Medical Technology and Pharmaceutical company. It platform technologies to build a comprehensive and proprietary portfolio of micro scale surgical and pharmaceutical therapies for glaucoma, corneal health and retinal diseases. The headquarters is in USA.
  6. Evolent Health

    World Rank (Jan-05-2024)
    3,681
    Market Cap (Jan-05-2024)
    3.758 Billion USD
    World Rank (Jul-30-2023)
    4,042
    Market Cap (Jul-30-2023)
    3.336 Billion USD
    World Rank (Dec-25-2022)
    4,358
    Market Cap (Dec-25-2022)
    2.767 Billion USD
    World Rank (Jan-07-2022)
    6,180
    Market Cap (Jan-07-2022)
    2.06 Billion USD
    Annual Revenue in USD
    1,352 Million USD
    Annual Operating Income in USD
    -20 Million USD
    Annual Net Income in USD
    -19 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile

    Evolent Health is comprised of an experienced and committed group of Health Care Professionals, unified by a passion for transforming the way care is delivered and experienced in the United States. The company annual revenue is 238.6 million USD. The headquarters is in USA.

  7. Organon & Co.

    World Rank (Jan-05-2024)
    3,693
    Market Cap (Jan-05-2024)
    3.740 Billion USD
    World Rank (Jul-30-2023)
    2,666
    Market Cap (Jul-30-2023)
    5.649 Billion USD
    World Rank (Dec-25-2022)
    2,026
    Market Cap (Dec-25-2022)
    7.098 Billion USD
    World Rank (Jan-07-2022)
    2,198
    Market Cap (Jan-07-2022)
    8.20 Billion USD
    Annual Revenue in USD
    6,174 Million USD
    Annual Net Income in USD
    917 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile

    Organon & Co is a Global Healthcare company with a mission to deliver impactful medicines and solutions. It is having more than 60 medicines and other products across a range of areas including reproductive health, heart disease, dermatology, allergies and asthma. The headquarters is in USA.

  8. Pharmaessentia Corporation

    World Rank (Jan-05-2024)
    3,704
    Market Cap (Jan-05-2024)
    3.726 Billion USD
    World Rank (Jul-30-2023)
    3,671
    Market Cap (Jul-30-2023)
    3.797 Billion USD
    World Rank (Dec-25-2022)
    2,835
    Market Cap (Dec-25-2022)
    4.782 Billion USD
    World Rank (Jan-07-2022)
    5,518
    Market Cap (Jan-07-2022)
    2.47 Billion USD
    Headquarters Country
    Company Profile
    PHARMAESSENTIA CORPORATION is a fully integrated global biopharmaceutical company delivering efficacious, safe and cost effective therapeutic products for the treatment of human diseases. The headquarters is in China.
  9. 1Life Healthcare Inc

    World Rank (Jan-05-2024)
    3,705
    World Rank (Jul-30-2023)
    3,705
    World Rank (Dec-25-2022)
    3,705
    Market Cap (Dec-25-2022)
    3.423 Billion USD
    World Rank (Jan-07-2022)
    4,919
    Market Cap (Jan-07-2022)
    2.94 Billion USD
    Annual Revenue in USD
    621 Million USD
    Annual Net Income in USD
    -254 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile

    1Life Healthcare is a Administrative and Managerial Services company for the affiliated One Medical is a membership based primary care service with in person care and online resources including a mobile app. The company annual revenue is 78.8 Million USD. The headquarters is in USA.

  10. Haisco Pharmaceutical Group

    World Rank (Jan-05-2024)
    3,705
    Market Cap (Jan-05-2024)
    3.725 Billion USD
    World Rank (Jul-30-2023)
    3,761
    Market Cap (Jul-30-2023)
    3.688 Billion USD
    World Rank (Dec-25-2022)
    3,889
    Market Cap (Dec-25-2022)
    3.219 Billion USD
    World Rank (Jan-07-2022)
    4,526
    Market Cap (Jan-07-2022)
    3.29 Billion USD
    Annual Revenue in USD
    404 Million USD
    Annual Net Income in USD
    50 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile
    HAISCO PHARMACEUTICAL GROUP is a chemical pharmaceutical industries company with manufacturer of drugs for liver disease. The company specialized fields of innovative drugs and high end generic drugs involving multiple disease fields such as anaesthesia and analgesia, diabetes mellitus and complications, tumour, neuralgia, parenteral nutrition, cardio-cerebrovascular, digestive and respiratory diseases. The headquarters is in China.

Share

Ads